{{Rsnum
|rsid=11568482
|Gene=SLC22A8
|Chromosome=11
|position=62995792
|Orientation=minus
|GMAF=0.01331
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=SLC22A8
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 95.2 | 4.8 | 0.0
| JPT | 97.6 | 2.4 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 95.2 | 4.8 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs11568482
|Name_s=SLC22A8: I305F
|Gene_s=SLC22A8
|Feature=Exon/NonSyn
|Evidence=PubMed ID:19940846
|Annotation=altered substrate specificity in transfected cells
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA165111580
}}

{{PMID Auto
|PMID=23649425
|Title=Reduced renal clearance of cefotaxime in asians with a low-frequency polymorphism of OAT3 (SLC22A8).
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}